Compounds > n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide
Page last updated: 2024-09-05

n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide and Disease Exacerbation

n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide has been researched along with Disease Exacerbation in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aamdal, S; Awada, A; Baron, B; Caponigro, F; Dittrich, C; Djurasinovic, N; Fumoleau, P; Gore, M; Lesimple, T; Punt, CJ; Ravic, M; Schöffski, P; Smyth, JF1

Trials

1 trial(s) available for n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide and Disease Exacerbation

ArticleYear
Phase II study of E7070 in patients with metastatic melanoma.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2005, Volume: 16, Issue:1

    Topics: Adult; Aged; Disease Progression; Female; Humans; Infusions, Intravenous; Male; Melanoma; Middle Aged; Skin Neoplasms; Sulfonamides; Treatment Outcome

2005